Fibrinogen administration in prehospital trauma

Cover image - FCThis report considers if Fibrinogen Concentrate (FC) is a reasonable alternative to allogeneic products in the prehospital setting by examining the literature regarding patient mortality, intensive care unit (ICU) length of stay, safety, need for additional blood products, storage, administration and costs.

Key points from the report:

  1. Current published evidence is low quality
  2. Suggests FC in hospital setting is safe and effective
  3. Logistic advantages for FC with storage, preparation and more rapid administration

Outcome:

In the absence of allogenic products, FC could be considered as a reasonable prehospital alternative. This is best conducted under clinical trial conditions.

Document

Fibrinogen administration in prehospital trauma

Contact

For more information please contact:

Jon Newman
Project Officer
NSW Institute of Trauma and Injury Management
+61 2 9464 4663
jonathan.newman@health.nsw.gov.au

ITIM Guidelines

Contact

Contact us

Events

Twitter

View all ITIM tweets

Video

Loading latest video...

See all videos